Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November - PR & Med Ed

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Cephalon

Targretin

Oncology

LeapFrog Medical

MSD

Univads website

N/A

LeapFrog Medical

Novo Nordisk

Healthspan range

Vitamins and minerals

Spink Consumer Relations

Reckitt Benckiser (global)

Nurofen

Pain

Virgo Health PR

Roche Products UK

Bondronat

Endocrine

Just::

Solvay

Creon

Cystic fibrosis

LeapFrog Medical

Takeda Europe

Actos

Type II diabetes

The Remedy, Fleishman-Hillard

Takeda Europe

Blopress

Hypertension

The Remedy, Fleishman-Hillard

Takeda Europe

Prostap SR

Prostate cancer

The Remedy, Fleishman-Hillard

Takeda Europe

Rozerem

Insomnia

The Remedy, Fleishman-Hillard

Takeda Europe

International medical meetings

N/A

The Remedy, Fleishman-Hillard

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics